Our results revealed that HSP60 silencing in U87 cells enhanced cellular ROS production through disruption of respiratory complex I and markedly suppressed cell growth and proliferation through activating the ROS-AMPK-mTOR pathway, suggesting that HSP60 is a potential target for GBM treatment. This evidence concerns the gene MTOR and glioblastoma.